What is Fludrocortisone?
Fludrocortisone is a synthetic mineralocorticoid medication used as replacement therapy for aldosterone deficiency in primary adrenal insufficiency (Addison's disease) and salt-losing forms of congenital adrenal hyperplasia. 1
Pharmacology and Mechanism
Fludrocortisone acetate (also known as 9-fluorohydrocortisone) is a potent synthetic steroid with strong mineralocorticoid activity—approximately equal to aldosterone in potency—but with a longer duration of action, making it more practical for clinical use 1, 2. It works by:
- Maintaining water and electrolyte homeostasis through sodium retention and potassium excretion
- Supporting blood pressure by increasing blood volume
- Acting primarily on renal mineralocorticoid receptors 3, 4
The medication also possesses some glucocorticoid activity, though it is prescribed specifically for its mineralocorticoid effects 1.
Clinical Indications
Primary Uses (FDA-Approved)
Fludrocortisone is indicated for:
- Primary adrenal insufficiency (Addison's disease) as partial replacement therapy
- Secondary adrenocortical insufficiency
- Salt-losing adrenogenital syndrome (congenital adrenal hyperplasia) 1
Key Clinical Context
All patients with confirmed aldosterone deficiency should receive mineralocorticoid replacement 3. However, there is one critical exception: fludrocortisone should NOT be used in glucocorticoid-induced adrenal insufficiency 5. This is because glucocorticoid-induced adrenal insufficiency represents secondary adrenal insufficiency where the renin-angiotensin-aldosterone system remains intact, so mineralocorticoid replacement is unnecessary and potentially harmful.
Dosing and Administration
Standard Dosing
- Adults and adolescents: 0.05-0.2 mg once daily, typically taken in the morning 3
- Children and newborns: Higher doses often required due to lower mineralocorticoid sensitivity 3
- The morning timing mimics the natural circadian rhythm of aldosterone secretion 3
Dose Adjustments
- Hot climates or excessive sweating: Increase dose by 50-100% or increase salt intake 3
- Patients on prednisolone: May require higher fludrocortisone doses (prednisolone has less mineralocorticoid activity) 3
- Patients on dexamethasone: Require full mineralocorticoid replacement (dexamethasone has no mineralocorticoid activity) 3
Monitoring
Monitor replacement primarily through clinical assessment 3:
Signs of Adequate Replacement
- Normal blood pressure without postural hypotension
- Absence of salt craving or lightheadedness
- Normal electrolytes (sodium and potassium)
- General sense of well-being
- Plasma renin activity in the upper reference range 3
Signs of Over-Replacement
- Hypertension
- Peripheral edema
- Hypokalemia
- Hypernatremia 4
Signs of Under-Replacement
- Postural hypotension
- Salt craving
- Lightheadedness when standing
- Hyperkalemia
Important Drug Interactions and Precautions
Avoid these substances as they potentiate mineralocorticoid effects:
- Licorice
- Grapefruit juice 3
Phenytoin increases fludrocortisone metabolism, potentially requiring higher replacement doses 3.
Management of Hypertension on Fludrocortisone
If hypertension develops while on fludrocortisone 3:
- First: Reduce the fludrocortisone dose
- Second: If blood pressure remains uncontrolled, initiate antihypertensive treatment while continuing fludrocortisone
- Preferred antihypertensives: Angiotensin II receptor blockers or ACE inhibitors (to counter vasoconstrictive effects of elevated angiotensin II)
- Second-line: Dihydropyridine calcium channel blockers
- Avoid: Diuretics and aldosterone receptor blockers (spironolactone, eplerenone are contraindicated) 3
Common Pitfalls
- Do not use fludrocortisone in glucocorticoid-induced adrenal insufficiency—this is the most important contraindication 5
- Evaluate both glucocorticoid AND mineralocorticoid doses when assessing hypertension in patients with primary adrenal insufficiency, as over-replacement with either can cause elevated blood pressure 3
- Long-term use requires monitoring for hypernatremia, hypokalemia, hyperglycemia, and congestive heart failure 4